MK-3903: A Potent AMPK Activator for Metabolic Research and Pharmaceutical Development
Discover the cutting-edge capabilities of MK-3903, a leading AMPK activator offering unparalleled selectivity and potency for your advanced research and pharmaceutical development needs.
Get a Quote & SampleProduct Core Value

MK-3903
As a trusted supplier in China, we offer MK-3903, a highly potent and selective AMP-activated protein kinase (AMPK) activator. This compound is crucial for researchers investigating metabolic pathways and developing new therapeutic agents. Our commitment as a manufacturer in China ensures high quality and consistent supply for your projects.
- Explore the precise mechanism of action for AMPK activation with MK-3903, a key compound for understanding cellular energy homeostasis.
- Investigate the in vivo studies of MK-3903 to understand its effects on fatty acid synthesis inhibition and insulin sensitization in various animal models.
- Leverage the detailed pharmacokinetic data of MK-3903 across mice, rats, and dogs for robust preclinical study design.
- Secure a reliable supply of this potent AMPK activator for research, ensuring consistent results in your drug discovery pipelines.
Advantages Offered by MK-3903
Unmatched Potency and Selectivity
MK-3903 stands out as a leading potent AMPK activator, demonstrating exceptional selectivity for its target, making it invaluable for precise scientific inquiry.
Versatile Research Applications
Utilize MK-3903 for critical research in metabolic syndrome therapeutics, offering insights into conditions like diabetes and obesity.
Reliable Pharmaceutical Intermediate
Source high-purity MK-3903, a vital pharmaceutical intermediate, from our reputable manufacturing facilities in China, ensuring your synthesis processes are efficient.
Key Applications
Metabolic Research
MK-3903 is instrumental in dissecting complex metabolic pathways and understanding the role of AMPK in energy balance, crucial for metabolic research.
Drug Discovery
As a foundational tool, MK-3903 supports the early stages of drug discovery, particularly for agents targeting metabolic disorders and related conditions.
AMPK Signaling Studies
Investigate the intricate details of AMPK signaling and its downstream effects with the precise activation provided by MK-3903.
Preclinical Development
The compound's well-documented in vivo studies make it a valuable asset for preclinical development, offering predictive insights into therapeutic efficacy.